Funding for this research was provided by:
China Scholarship Council (201600160066)
VetenskapsrÄdet (2016-01153, 2016-01154)
Horizon 2020 Framework Programme (668353)
Article History
Received: 25 December 2019
Accepted: 16 March 2020
First Online: 23 March 2020
Compliance with ethical standards
:
: VML is co-founder and shareholder of HepaPredict AB. QX and YZ have no conflicts of interest to declare.